Back

Extracellular chaperones modulate AL light chains fibrillar aggregation and contribute to amyloid structural heterogeneity

Marchese, L.; Battaglia, M.; Mangione, P. P.; Relini, A.; Codroico, G.; Raimondi, S.; Forneris, F.; Faravelli, S.; Leonardini, B.; Canale, C.; Verona, G.; Canetti, D.; Bellotti, V.; Giorgetti, S.; Corazza, A.; Lavatelli, F.

2026-06-02 biochemistry
10.64898/2026.05.29.728721 bioRxiv
Show abstract

In AL amyloidosis, monoclonal immunoglobulin light chains (LCs) aggregate as amyloid fibrils in tissues. In synergy with the intrinsic aggregation propensity of specific LC sequences, microenvironment factors may be involved in tuning the disease pathophysiology, in particular proteolytic LC remodelling and heterotypic interactions in the extracellular milieu. Accounting for extrinsic modulators is critical for understanding the phenotypic variability of AL, usually imputed mainly to the LC diversity. We investigated the effects of apolipoprotein E (allele 3, apoE3) and clusterin (CLU), two amyloid-signature proteins involved in extracellular proteostasis, on the fibrillogenesis kinetics of amyloidogenic LC fragments from patient-derived sequences, as well as on aggregate composition, fibril morphology and thermodynamic stability. We show that apoE3 and CLU act as heterotypic interactors of prefibrillar and fibrillar LCs, significantly modulating LC amyloidogenesis, with complex and non-monotypic effects that range from anti- to pro-amyloidogenic depending on their concentration and on the LCs intrinsic amyloidogenicity. ApoE3 and CLU also influence fibril morphology, possibly by modifying protofilament association, and alter their thermodynamic properties. LC interactors may play a significant and insofar underappreciated role in the AL pathophysiology in vivo, likely contributing to phenotypic variability and structural polymorphisms and, possibly, to fibril resilience to amyloid reabsorption strategies.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Brain
154 papers in training set
Top 0.2%
17.4%
2
Nature Communications
4913 papers in training set
Top 23%
8.4%
3
Blood
67 papers in training set
Top 0.3%
6.3%
4
eLife
5422 papers in training set
Top 17%
4.8%
5
Neurobiology of Disease
134 papers in training set
Top 1%
3.9%
6
Matrix Biology
28 papers in training set
Top 0.1%
3.2%
7
Scientific Reports
3102 papers in training set
Top 41%
3.1%
8
Communications Biology
886 papers in training set
Top 3%
2.7%
9
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 30%
1.9%
50% of probability mass above
10
Alzheimer's & Dementia
143 papers in training set
Top 2%
1.7%
11
Cell Reports
1338 papers in training set
Top 24%
1.7%
12
iScience
1063 papers in training set
Top 15%
1.7%
13
Cells
232 papers in training set
Top 2%
1.7%
14
Journal of Biological Chemistry
641 papers in training set
Top 2%
1.7%
15
Journal of Molecular Biology
217 papers in training set
Top 2%
1.3%
16
Life Science Alliance
263 papers in training set
Top 0.6%
1.3%
17
The EMBO Journal
267 papers in training set
Top 3%
1.3%
18
Computational and Structural Biotechnology Journal
216 papers in training set
Top 6%
1.3%
19
JCI Insight
241 papers in training set
Top 5%
1.2%
20
Advanced Science
249 papers in training set
Top 14%
1.2%
21
Haematologica
24 papers in training set
Top 0.3%
1.2%
22
PLOS Pathogens
721 papers in training set
Top 7%
1.2%
23
Journal of the American Chemical Society
199 papers in training set
Top 4%
0.9%
24
International Journal of Molecular Sciences
453 papers in training set
Top 13%
0.9%
25
Biomolecules
95 papers in training set
Top 2%
0.8%
26
Science Translational Medicine
111 papers in training set
Top 6%
0.8%
27
PLOS Computational Biology
1633 papers in training set
Top 23%
0.8%
28
Molecular Neurodegeneration
49 papers in training set
Top 0.9%
0.7%
29
Journal of Clinical Investigation
164 papers in training set
Top 7%
0.7%
30
JACC: Basic to Translational Science
15 papers in training set
Top 0.5%
0.7%